The UK has received 30 reports of the rare blood clotting events that have been linked to the Oxford/AstraZeneca Covid-19 vaccine in recent weeks and have caused precautionary restrictions to be placed on its use in many European countries.
On Thursday evening, the Medicines and Healthcare products Regulatory Agency released information about 25 new cases of severe and very rare blood clotting events, on top of five it had reported earlier this month.
The MHRA also clarified that it had not seen any of the same reactions in individuals that had received the BioNTech/Pfizer vaccine.
您已閱讀18%（586字），剩餘82%（2692字）包含更多重要資訊，訂閱以繼續探索完整內容，並享受更多專屬服務。